- Messages
- 31
- Type of diabetes
- Researcher
- Treatment type
- Other
I briefly discussed my undiagnosed pathology about six weeks ago in response to a poster's question. I am restating the problem in its own thread in great depth for wider review. I am a 70 year old retired scientist. I'd appreciate any input this community may offer.
A Lay Opinion of the Clinical Picture
A slowly progressive systemic dysfunction of uncertain etiology has presented for more than ten years. Suggestive of a chronic dysmetabolism syndrome, it is triggered by ingesting even minute amounts of carbohydrates. Its acute symptoms--including most prominently distal numbness--are partially relieved by repletion with Methylcobalamin (MeCbl), a bioactive cofactor of B-12 that provides cellular methylation in addition to B-12 itself.
The array of clinical manifestations includes the characteristic B-12 deficiency triad of neurological, hematological, and psychiatric symptoms; foamy transformed macrophages; apparent connective tissue inelasticity; Alpha-1 Antitrypsin Deficiency (S-variant allele); a 1.3 cm renal mass cryoablated Nov 2016; and numerous other deficits, many consistent with a B-12 malabsorption or dysmetabolism pathology.
As has been reported in the scientific literature, high-dose vitamin B-12 can overcome pathway deficits in some patients, perhaps related to the more recent finding that B-12 cofactors MeCbl or Adenosylcobalamin (AdoCbl) may have a significant stabilizing effect on the MMACHC (cobalamin C) protein. In this patient’s case, repletion and ongoing titration with MeCbl and AdoCbl, and B-9 Methylfolate (MeFolate) in therapeutic doses begun in 2014 initially resulted in dramatic biochemical and clinical improvement.
However, neurologic deficits have progressed to the severe level with a January 2018 Dx of severe sensorimotor polyneuropathy (SMPN) with axonal features and denervation. Nonetheless, in mid-2016, adoption of a fat-oriented very low carb ketogenic diet to bypass the dysfunctional carbohydrate metabolic pathway has further slowed accumulating deficits. Currently, MeCbl is administered subQ: 0.33 cc every other day @ 25 mg/mL. AdoCbl and MeFolate are given orally @ 1.5 mg and 0.8 mg every other day. SAMe, 200 mg, is taken every other day.
Importantly, a diagnostic clue may be found in the lack of effectiveness of the standard-of-care Cyanocobalamin (CyCbl) and the dramatic therapeutic response to B-12 cofactor repletion (MeCbl, AdoCbl). It may indicate the end stage cobalamin pathway reduction is never realized because from a CyCbl administration for the patient neither the cytoplasm methylation to form MeCbl, nor mitochondrial adenosylation to form AdoCbl occurs. Alternatively, it may suggest the effectiveness of the MeCbl repletion is more a function of the applied cellular methylation by influencing gene expression. For example, methylation is a process now known to improve some systemic diabetes manifestations.
Current Syndrome of this Metabolic Pathology
More recently, within just hours now of consuming carbohydrates (and to lesser detrimental effect, food cholesterol), an acutely arising distal numbness presents that can advance into the torso. Thereafter affected are balance, mobility, motor coordination, proprioception, waste elimination, strength, stamina, a burning mouth syndrome, and days later, psych profile alterations and apparent connective tissue inelasticity. A positive Romberg can re-emerge.
These deficits increase in severity over time (up to three+ days) proportional to the amount of carbohydrates consumed, and then wane with the repletion dosing of MeCbl injections. Over the past eight years, the latency period after carbohydrate consumption and the appearance of distal numbness has closed from days to one hour, and distal neurologic deficits have advanced to severe SMPN with axonal features and denervation. Distal nerve damage is visually apparent with permanent sluggishness in movement and coarseness in lower/upper limb and phalanges articulation. The patient cannot coordinate running; walking is often labored, limited to 100 yards at a time. Unaided stair climbing is impossible beyond ten steps. More specifically,
1) Hematologic: transient mild pancytopenia; leading thrombocytopenia (105: 160-410); reticulocytopenia (#0.03: 0.05-0.11); transient mild leukopenia, erythropenia, monocytopenia. Abnormal platelets.
2) Neurologic: progressive, severe SMPN with axonal features and denervation, painless, symmetric, stocking-glove (B-12 deficiency type), entrapment across elbow. Gait, foot-drop, balance, coordination, and stamina deficits worsening within hours of consuming carbohydrates. Moderate proprioception errors; sensory ataxia appears. Walking is stiff, sluggish, weighted, and distance-limited particularly when under carbohydrate dysmetabolism stress. Chronic absent deep tendon reflexes, moderate hand tremor.
3) Gastroenterologic: NAFLD. Splenomegaly. 2017 liver biopsy showed glycogenated nuclei and trace positive iron stain in macrophages. Portal tracts contained a sparse lymphocytic infiltrate. Until three years ago, periodically explosive diarrhea and abdominal pain largely relieved by a reduction in dietary carbohydrates. Diverticulitis Dx 2005. A 2017 SIBO test (hydrogen only) was negative.
4) Psychiatric: When under extended challenges from either carbohydrate dysmetabolism stress or a trial reduction in MeCbl repletion: memory loss, brain fog, confusion, depression, anger, paranoia, word searching, presentation anxiety, and combat PTSD symptoms appear or are acutely exacerbated.
5) Endocrinologic: Enlarged abdominal lymph nodes. Chronically well below RR Alkaline Phosphatase. Lipids: TC 226 (ketogenic dietary necessity of fatty meats). TC/HDL 3.8. Glucose: 112. A1C typically 4.8 but now 5.3 due to periodic carbohydrate consumption challenges.
6) Physical: Frequent thirst. Foamy transformed macrophages from biopsy preceding 2012 rib resection. Presumed connective tissue inelasticity. Leg muscle atrophy, infrequent calf and tibial bone pain. Chronic mild cubital tunnel syndrome (R arm, dominant) and mild carpal tunnel syndrome (L). Persistent sinusitis during adult life; sinus infections ended after MeCbl repletion began in 2014. Multiple direct exposures to organophosphates (Agents Orange, Blue, White) in Vietnam (1969-1970).
7) Ophthalmologic: Occasional blurry vision. EBMD corneal dystrophy (Dx prior to 2014), cataracts. Events of wavy, shimmering lights (Dx painless migraines). Sensitivity to light relieved by MeCbl repletion.
What Happens When Carbs are Consumed?
Several years ago, when the association between carb consumption and acutely arising distal numbness was first realized, the latency period between the events was about 2-3 days. Since then, the carb consumption to the start of distal numbness period has dropped to about an hour.
1) Example: 25 carb grams at dinnertime of hamburger potato bun.
2) About one hour later, soles of feet and foot tops/sides, fingers are beginning to numb; articulation diminishes.
3) During subsequent sleep period, action of stretching legs usually causes calf muscle cramping.
4) In morning at wakeup, walking has become stiff, stilted as lower legs and feet have numbed. Seemingly, all neurologic deficits have worsened. Sense of lethargy ensues.
It may take three or more days for the additional numbness to resolve, often not fully. If the carb consumption has been large enough, ataxia and psychiatric disturbances follow. (B-12 molecules not crossing the BBB to the CSF?)
***
A Lay Opinion of the Clinical Picture
A slowly progressive systemic dysfunction of uncertain etiology has presented for more than ten years. Suggestive of a chronic dysmetabolism syndrome, it is triggered by ingesting even minute amounts of carbohydrates. Its acute symptoms--including most prominently distal numbness--are partially relieved by repletion with Methylcobalamin (MeCbl), a bioactive cofactor of B-12 that provides cellular methylation in addition to B-12 itself.
The array of clinical manifestations includes the characteristic B-12 deficiency triad of neurological, hematological, and psychiatric symptoms; foamy transformed macrophages; apparent connective tissue inelasticity; Alpha-1 Antitrypsin Deficiency (S-variant allele); a 1.3 cm renal mass cryoablated Nov 2016; and numerous other deficits, many consistent with a B-12 malabsorption or dysmetabolism pathology.
As has been reported in the scientific literature, high-dose vitamin B-12 can overcome pathway deficits in some patients, perhaps related to the more recent finding that B-12 cofactors MeCbl or Adenosylcobalamin (AdoCbl) may have a significant stabilizing effect on the MMACHC (cobalamin C) protein. In this patient’s case, repletion and ongoing titration with MeCbl and AdoCbl, and B-9 Methylfolate (MeFolate) in therapeutic doses begun in 2014 initially resulted in dramatic biochemical and clinical improvement.
However, neurologic deficits have progressed to the severe level with a January 2018 Dx of severe sensorimotor polyneuropathy (SMPN) with axonal features and denervation. Nonetheless, in mid-2016, adoption of a fat-oriented very low carb ketogenic diet to bypass the dysfunctional carbohydrate metabolic pathway has further slowed accumulating deficits. Currently, MeCbl is administered subQ: 0.33 cc every other day @ 25 mg/mL. AdoCbl and MeFolate are given orally @ 1.5 mg and 0.8 mg every other day. SAMe, 200 mg, is taken every other day.
Importantly, a diagnostic clue may be found in the lack of effectiveness of the standard-of-care Cyanocobalamin (CyCbl) and the dramatic therapeutic response to B-12 cofactor repletion (MeCbl, AdoCbl). It may indicate the end stage cobalamin pathway reduction is never realized because from a CyCbl administration for the patient neither the cytoplasm methylation to form MeCbl, nor mitochondrial adenosylation to form AdoCbl occurs. Alternatively, it may suggest the effectiveness of the MeCbl repletion is more a function of the applied cellular methylation by influencing gene expression. For example, methylation is a process now known to improve some systemic diabetes manifestations.
Current Syndrome of this Metabolic Pathology
More recently, within just hours now of consuming carbohydrates (and to lesser detrimental effect, food cholesterol), an acutely arising distal numbness presents that can advance into the torso. Thereafter affected are balance, mobility, motor coordination, proprioception, waste elimination, strength, stamina, a burning mouth syndrome, and days later, psych profile alterations and apparent connective tissue inelasticity. A positive Romberg can re-emerge.
These deficits increase in severity over time (up to three+ days) proportional to the amount of carbohydrates consumed, and then wane with the repletion dosing of MeCbl injections. Over the past eight years, the latency period after carbohydrate consumption and the appearance of distal numbness has closed from days to one hour, and distal neurologic deficits have advanced to severe SMPN with axonal features and denervation. Distal nerve damage is visually apparent with permanent sluggishness in movement and coarseness in lower/upper limb and phalanges articulation. The patient cannot coordinate running; walking is often labored, limited to 100 yards at a time. Unaided stair climbing is impossible beyond ten steps. More specifically,
1) Hematologic: transient mild pancytopenia; leading thrombocytopenia (105: 160-410); reticulocytopenia (#0.03: 0.05-0.11); transient mild leukopenia, erythropenia, monocytopenia. Abnormal platelets.
2) Neurologic: progressive, severe SMPN with axonal features and denervation, painless, symmetric, stocking-glove (B-12 deficiency type), entrapment across elbow. Gait, foot-drop, balance, coordination, and stamina deficits worsening within hours of consuming carbohydrates. Moderate proprioception errors; sensory ataxia appears. Walking is stiff, sluggish, weighted, and distance-limited particularly when under carbohydrate dysmetabolism stress. Chronic absent deep tendon reflexes, moderate hand tremor.
3) Gastroenterologic: NAFLD. Splenomegaly. 2017 liver biopsy showed glycogenated nuclei and trace positive iron stain in macrophages. Portal tracts contained a sparse lymphocytic infiltrate. Until three years ago, periodically explosive diarrhea and abdominal pain largely relieved by a reduction in dietary carbohydrates. Diverticulitis Dx 2005. A 2017 SIBO test (hydrogen only) was negative.
4) Psychiatric: When under extended challenges from either carbohydrate dysmetabolism stress or a trial reduction in MeCbl repletion: memory loss, brain fog, confusion, depression, anger, paranoia, word searching, presentation anxiety, and combat PTSD symptoms appear or are acutely exacerbated.
5) Endocrinologic: Enlarged abdominal lymph nodes. Chronically well below RR Alkaline Phosphatase. Lipids: TC 226 (ketogenic dietary necessity of fatty meats). TC/HDL 3.8. Glucose: 112. A1C typically 4.8 but now 5.3 due to periodic carbohydrate consumption challenges.
6) Physical: Frequent thirst. Foamy transformed macrophages from biopsy preceding 2012 rib resection. Presumed connective tissue inelasticity. Leg muscle atrophy, infrequent calf and tibial bone pain. Chronic mild cubital tunnel syndrome (R arm, dominant) and mild carpal tunnel syndrome (L). Persistent sinusitis during adult life; sinus infections ended after MeCbl repletion began in 2014. Multiple direct exposures to organophosphates (Agents Orange, Blue, White) in Vietnam (1969-1970).
7) Ophthalmologic: Occasional blurry vision. EBMD corneal dystrophy (Dx prior to 2014), cataracts. Events of wavy, shimmering lights (Dx painless migraines). Sensitivity to light relieved by MeCbl repletion.
What Happens When Carbs are Consumed?
Several years ago, when the association between carb consumption and acutely arising distal numbness was first realized, the latency period between the events was about 2-3 days. Since then, the carb consumption to the start of distal numbness period has dropped to about an hour.
1) Example: 25 carb grams at dinnertime of hamburger potato bun.
2) About one hour later, soles of feet and foot tops/sides, fingers are beginning to numb; articulation diminishes.
3) During subsequent sleep period, action of stretching legs usually causes calf muscle cramping.
4) In morning at wakeup, walking has become stiff, stilted as lower legs and feet have numbed. Seemingly, all neurologic deficits have worsened. Sense of lethargy ensues.
It may take three or more days for the additional numbness to resolve, often not fully. If the carb consumption has been large enough, ataxia and psychiatric disturbances follow. (B-12 molecules not crossing the BBB to the CSF?)
***